Precision medicine is radically altering the development of treatments. Its personalized, focused approach to health care has a broad impact on everything from genomics to medical devices, and as a result, it is spawning new revenue models for companies across the industry. Precision medicine, moreover, provides a backdrop for researchers to investigate how genetic, environmental, and behavioral factors interact in human bodies to promote health or disease development. Precision medicine's crucial benefits are being brought to market thanks to new technology. These include the ability to enhance chronic illness patient outcomes, an improvement in product pipeline and speed-to-market for life sciences companies, and the ability to quickly remove research routes that are unlikely to succeed. Personalized medicine has been recognized as the next generation of diagnosis and therapy as a result of significant technical developments in this field.
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Personalized and precision medicine (PPM) can be established as a unique healthcare model through biodesign-driven and inspired biotech, translational applications. This approach aims to ensure human healthcare, wellness, and biosafety.
Sergey Suchkov, Institute for Biotech & Global Health of RosBioTech and A.I. Evdokimov MGMSU, Russian Federation
Title : Monitoring folds localization in ultra-thin transition metal dichalcogenides using optical harmonic generation
Ahmed Raza Khan, Australian National University, Australia
Title : A systematic review of regulatory approaches for Direct- To- Consumers (DTC) genetic testing
Kavitha Palaniappan, Duke-NUS Medical School, Singapore
Title : Regulatory framework of in vitro diagnostic and artificial intelligence for precision medicine
Pei Ting Sarah Chou, Regulatory Affairs Professionals Society, Taiwan
Title : Unraveling cancer stem cell signatures in circulating tumor cells of metastatic colorectal cancer: Investigating ALDH1A1 and the repurposing potential of disulfiram via scRNA-seq
Nurul Syakima Ab Mutalib, Universiti Kebangsaan Malaysia, Malaysia